LASSBio-542: Novel Thalidomide Analog Distinctly Modulates IL-10 and Inhibits Angiogenesis

E-ISSN： 1875-6646|8|2|167-175

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.8, Iss.2, 2012-06, pp. : 167-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A novel adenosine analog, AMP579, inhibits neutrophil activation, adherence and neutrophil-mediated injury to coronary vascular endothelium

By Nakamura M. Zhao Z.-Q. Clark K.L. Velez D.V. Guyton R.A. Vinten-Johansen J.

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 197-205

Elsevier

Access to resources Recommend Favorite

Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity

By Pul Refik

Journal of Neuroimmune Pharmacology, Vol. 6, Iss. 3, 2011-09 ,pp. : 381-388

Springer Publishing Company

Access to resources Recommend Favorite

Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells

Current Neuropharmacology, Vol. 9, Iss. 1, 2011-03 ,pp. : 195-199

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Novel Uses of Thalidomide: Focus on Palliative Care

By Peuckmann V.

Drugs, Vol. 60, Iss. 2, 2000-08 ,pp. : 273-292

Adis International

Access to resources Recommend Favorite

PI-88: a novel inhibitor of angiogenesis

By Kudchadkar Ragini Gonzalez Rene Lewis Karl D

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1769-1776

Informa Healthcare

Access to resources Recommend Favorite